All Stories

  1. Phytochemistry and Biological Effects of the Juglans regia “Sorrento” Walnut Husk Extract on Human Keratinocyte Cells
  2. Concentrated Growth Factor Induces ER Stress and Apoptosis by Increasing Ceramide Generation in Selected Tumour Cell Lines
  3. Exploring the Role of Oleic Acid in Muscle Cell Differentiation: Mechanisms and Implications for Myogenesis and Metabolic Regulation in C2C12 Myoblasts
  4. Pharmacological potential of endocannabinoid and endocannabinoid-like compounds in protecting intestinal structure and metabolism under high-fat conditions
  5. Insight into the Regulation of NDRG1 Expression
  6. Unraveling the protein kinase C/NDRG1 signaling network in breast cancer
  7. Exploring the Therapeutic Potential of Cannabidiol in U87MG Cells: Effects on Autophagy and NRF2 Pathway
  8. Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPARα activation in liver cells
  9. A Structure‐Activity Relationship Study of Amino Acid Derivatives of Pterostilbene Analogues Toward Human Breast Cancer
  10. M1-derived extracellular vesicles polarize recipient macrophages into M2-like macrophages and alter skeletal muscle homeostasis in a hyper-glucose environment
  11. Senescent Endothelial Cells Sustain Their Senescence-Associated Secretory Phenotype (SASP) through Enhanced Fatty Acid Oxidation
  12. PCOS and vitamin D: a clinical appraisal
  13. An aqueous olive leaf extract (OLE) ameliorates parameters of oxidative stress associated with lipid accumulation and induces lipophagy in human hepatic cells
  14. Editorial: Tumor microenvironment signaling networks in pathophysiology and therapeutics
  15. Androgen receptor in breast cancer: The “5W” questions
  16. Downstream Signaling of Inflammasome Pathway Affects Patients’ Outcome in the Context of Distinct Molecular Breast Cancer Subtypes
  17. Editorial: Lipid Orchestrated Signaling in Physiology and Pathology
  18. The Biological Relevance of NHERF1 Protein in Gynecological Tumors
  19. Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion
  20. Nutritional Regimes Enriched with Antioxidants as an Efficient Adjuvant for IBD Patients under Infliximab Administration, a Pilot Study
  21. Tumor Microenvironment Signaling Networks in Pathophysiology and Therapeutics
  22. Oxidative Stress and Multi-Organel Damage Induced by Two Novel Phytocannabinoids, CBDB and CBDP, in Breast Cancer Cells
  23. Differential Glycosylation Levels in Saliva from Patients with Lung or Breast Cancer: A Preliminary Assessment for Early Diagnostic Purposes
  24. Oleoylethanolamide Reduces Hepatic Oxidative Stress and Endoplasmic Reticulum Stress in High-Fat Diet-Fed Rats
  25. Investigation on the Composition of Agarose–Collagen I Blended Hydrogels as Matrices for the Growth of Spheroids from Breast Cancer Cell Lines
  26. Protein Kinase C Activation Drives a Differentiation Program in an Oligodendroglial Precursor Model through the Modulation of Specific Biological Networks
  27. Editorial: Dietary Antioxidants and Metabolic Diseases
  28. Vitamin D: Mechanism of Action and Biological Effects in Uterine Fibroids
  29. Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis
  30. Flow Cytometry Analysis of Circulating Extracellular Vesicle Subtypes from Fresh Peripheral Blood Samples
  31. Microbiota-Derived Metabolites in Tumor Progression and Metastasis
  32. Dystocia, Uterine Healing and Uterine Innervation: An Unexplored Intersection
  33. Alternative proteins are functional regulators in cell reprogramming by PKA activation
  34. Extracellular Vesicles as Signaling Mediators and Disease Biomarkers across Biological Barriers
  35. The Biological Impact of Ulipristal Acetate on Cellular Networks Regulating Uterine Leiomyoma Growth
  36. Adrenergic and Cholinergic Uterine Innervation and the Impact on Reproduction in Aged Women
  37. A Hidden Human Proteome Signature Characterizes the Epithelial Mesenchymal Transition Program
  38. 3D-microenvironments initiate TCF4 expression rescuing nuclear β-catenin activity in MCF-7 breast cancer cells
  39. Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling
  40. The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression
  41. The multiverse nature of epithelial to mesenchymal transition
  42. Lipid profiling of parkin-mutant human skin fibroblasts
  43. Distinct Protein Expression Networks are Activated in Microglia Cells after Stimulation with IFN-γ and IL-4
  44. Oxidative Molecular Mechanisms Underlying Liver Diseases: From Systems Biology to the Personalized Medicine
  45. NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus
  46. A specific lipid metabolic profile is associated with the epithelial mesenchymal transition program
  47. Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes
  48. Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet
  49. An SPR based immunoassay for the sensitive detection of the soluble epithelial marker E-cadherin
  50. Uterine Fibroids: From Molecular Oncology to Reproduction
  51. Quartz Crystal Microbalance as Cell-Based Biosensor to Detect and Study Cytoskeletal Alterations and Dynamics
  52. β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy
  53. Proteomic expression profile of injured rat peripheral nerves revealed biological networks and processes associated with nerve regeneration
  54. The Many-Faced Program of Epithelial–Mesenchymal Transition: A System Biology-Based View
  55. Uterine-Preserving Operative Therapy of Uterus Myomatosus
  56. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease
  57. β-Catenin Knockdown Affects Mitochondrial Biogenesis and Lipid Metabolism in Breast Cancer Cells
  58. Abstract 367: Trop-2 activates a dormant Na+/K+-ATPase/PKCα/CD9/ezrin signaling axis to override the basal growth program of cancer cells
  59. Platinum-induced mitochondrial DNA mutations confer lower sensitivity to paclitaxel by impairing tubulin cytoskeletal organization
  60. The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma
  61. Fats for thoughts: An update on brain fatty acid metabolism
  62. Lipid profiling of parkin -mutant human skin fibroblasts
  63. Resveratrol Modulation of Protein Expression in parkin-Mutant Human Skin Fibroblasts: A Proteomic Approach
  64. Anticancer effects of novel resveratrol analogues on human ovarian cancer cells
  65. Neurotransmitters and Neuropeptides Expression in the Uterine Scar After Cesarean Section
  66. A Proteomic Analysis of Human Uterine Myoma
  67. A Qualitative and Quantitative Study of the Innervation of the Human Non Pregnant Uterus
  68. Angiogenesis and Vascularization of Uterine Leiomyoma: Clinical Value of Pseudocapsule Containing Peptides and Neurotransmitters
  69. Laminin and Collagen IV: Two Polypeptides as Marker of Dystocic Labor
  70. Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics
  71. Comparative proteomic profiling of Hodgkin lymphoma cell lines
  72. Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients
  73. Frontispiece
  74. Polymer-Coated Magnetic Nanoparticles for Curcumin Delivery to Cancer Cells
  75. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells
  76. Transgenic Plants as Low-Cost Platform for Chemotherapeutic Drugs Screening
  77. Selective genetic analysis of myoma pseudocapsule and potential biological impact on uterine fibroid medical therapy
  78. Genetic and Genomics of Uterine Myomas
  79. A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target
  80. Cytoskeletal alterations of parkin-mutant human primary fibroblasts
  81. Molecular and biochemical alterations in epithelial to mesenchymal transition
  82. Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target
  83. Antitumor activity of the dietary diterpene carnosol against a panel of human cancer cell lines
  84. Management of Hereditary Ovarian–Breast Cancer
  85. The opioid neuropeptides in uterine fibroid pseudocapsules: a putative association with cervical integrity in human reproduction
  86. Comparative proteome profiling of breast tumor cell lines by gel electrophoresis and mass spectrometry reveals an epithelial mesenchymal transition associated protein signature
  87. The mRNA-HPV Test Utilization in the Follow Up of HPV Related Cervical Lesions
  88. Efficient stabilization of natural curcuminoids mediated by oil body encapsulation
  89. New bioactive compounds of vegetable sources in cancer therapy
  90. Time is moving fast
  91. The Impact of Proteomics in the Understanding of the Molecular Basis of Paclitaxel-Resistance in Ovarian Tumors
  92. Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer
  93. Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells
  94. Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells
  95. New molecules in the ovarian cancer therapy
  96. Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells
  97. Epithelial–mesenchymal transition in ovarian cancer
  98. Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal
  99. IFN-β reverses the lipopolysaccharide-induced proteome modifications in treated astrocytes
  100. Biomolecular Pathogenesis of Borderline Ovarian Tumors: Focusing Target Discovery Through Proteogenomics
  101. Age-related pelvic floor modifications and prolapse risk factors in postmenopausal women
  102. HPV Viral Activity by mRNA-HPV Molecular Analysis to Screen the Transforming Infections in Precancer Cervical Lesions
  103. Biomechanical and proteomic analysis of INF- β-treated astrocytes
  104. Retraction Notice: An Outlook on Ovarian Cancer and Borderline Ovarian Tumors: Focus on Genomic and Proteomic Findings
  105. MALDI Imaging Mass Spectrometry: STATE OF THE ART TECHNOLOGY IN CLINICAL PROTEOMICS
  106. PBMCs protein expression profile in relapsing IFN-treated multiple sclerosis: A pilot study on relation to clinical findings and brain atrophy
  107. Effects of visceral peritoneal closure on scar formation at cesarean delivery
  108. Cytomechanical and topological investigation of MCF-7 cells by scanning force microscopy
  109. Closure Versus Non-Closure of the Visceral Peritoneum (VP) in Patients with Gestational Hypertension—An Observational Analysis
  110. Myoma pseudocapsule: A distinct endocrino-anatomical entity in gynecological surgery
  111. Endometriosis Management: Workflow on Genomics and Proteomics and Future Biomolecular Pharmacotherapy
  112. Proteomic map of peripheral blood mononuclear cells
  113. Abdominopelvic tuberculosis in gynaecology: Laparoscopical and new laboratory findings
  114. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: A clinical review
  115. Ovarian Cancer Biomarkers: A Focus on Genomic and Proteomic Findings
  116. Human papillomavirus genital infection in modern gynecology: genetic and genomic aspects
  117. Emergency surgical procedure for failed methotrexate treatment of cervical pregnancy: A case report